Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 2, 2010, Pages

  Yang, H H Clarice ^a   Kim, Jong Moo ^a   Chum, Elliott ^a   Van Breemen, Cornelis ^a   Chung, Ada W Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

metalloproteinase; MMP; TAA; TGF ; thoracic aortic aneurysm; TIMP; tissue inhibitor of metalloproteinase; transforming growth factor

Indexed keywords

DOXYCYCLINE; GELATINASE A; GELATINASE B; LOSARTAN POTASSIUM; TRANSFORMING GROWTH FACTOR BETA;

AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELASTIC FIBER; ENZYME REGULATION; MARFAN SYNDROME; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECONDARY PREVENTION; THORACIC AORTA; THORACIC AORTA ANEURYSM;

EID: 77955473542     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.10.039     Document Type: Article

References (33)

1. D.P. Judge, and H.C. Dietz Marfan's syndrome Lancet 366 2005 1965 1976
2. J. Shores, K.R. Berger, E.A. Murphy, and R.E. Pyeritz Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan's syndrome N Engl J Med 330 1994 1335 1341
3. A.S. Rios, E.N. Silber, N. Bavishi, P. Varga, B.K. Burton, W.A. Clark, and P. Denes Effect of long-term β-blockade on aortic root compliance in patients with Marfan syndrome Am Heart J 137 1999 1057 1061
4. F.C. Yin, K.P. Brin, C.T. Ting, and R.E. Pyeritz Arterial hemodynamic indexes in Marfan's syndrome Circulation 79 1989 854 862
5. A.W. Chung, H.H.C. Yang, M.W. Radomski, and C. van Breemen Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9 Circ Res 102 2008 e73 e85
6. A.W. Chung, K. Au Yeung, G.G. Sandor, D.P. Judge, H.C. Dietz, and C. van Breemen Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome Circ Res 101 2007 512 522
7. A.W. Chung, K. Au Yeung, S.F. Cortes, G.G. Sandor, D.P. Judge, and H.C. Dietz et al. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome Br J Pharmacol 150 2007 1075 1083
8. J.P. Habashi, D.P. Judge, T.M. Holm, R.D. Cohn, B.L. Loeys, and T.K. Cooper et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome Science 312 2006 117 121
9. E.R. Neptune, P.A. Frischmeyer, D.E. Arking, L. Myers, T.E. Bunton, and B. Gayraud et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 2003 407 411
10. P. Matt, J. Habashi, T. Carrel, D.E. Cameron, J.E. Van Eyk, and H.C. Dietz Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg 135 2008 389 394
11. M. Nataatmadja, M. West, J. West, K. Summers, P. Walker, and M. Nagata et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm Circulation 2003 108 (1 Suppl):II329-34
12. J.S. Ikonomidis, J.A. Jones, J.R. Barbour, R.E. Stroud, L.L. Clark, and B.S. Kaplan et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome Circulation 114 1 Suppl 2006 I365 I370
13. K.B. Jones, L. Myers, D.P. Judge, P.A. Kirby, H.C. Dietz, and P.D. Sponseller Toward an understanding of dural ectasia: a light microscopy study in a murine model of Marfan syndrome Spine 30 2005 291 293
14. Y.P. Han, T.L. Tuan, M. Hughes, H. Wu, and W.L. Garner Transforming growth factor-β- and tumor necrosis factor-α-mediated induction and proteolytic activation of MMP-9 in human skin J Biol Chem 276 2001 22341 22350
15. 1-type II receptor signaling within the aged arterial wall Arterioscler Thromb Vasc Biol 26 2006 1503 1509
16. 1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events Ann Thorac Surg 83 2007 946 953
17. S.K. Karnik, B.S. Brooke, A. Bayes-Genis, L. Sorensen, J.D. Wythe, and R.S. Schwartz et al. A critical role for elastin signaling in vascular morphogenesis and disease Development 130 2003 411 423
18. E.C. Davis Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization Lab Invest 68 1993 89 99
19. H. Sakamoto, T. Broekelmann, D.A. Cheresh, F. Ramirez, J. Rosenbloom, and R.P. Mecham Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1 J Biol Chem 271 1996 4916 4922
20. 2+ entry mechanisms of vascular contraction J Vasc Surg 40 2004 1001 1010
21. X.K. Tong, and E. Hamel Transforming growth factor-β 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase Mol Pharmacol 72 2007 1476 1483
22. K. Sharma, L. Deelman, M. Madesh, B. Kurz, E. Ciccone, and S. Siva et al. Involvement of transforming growth factor-β in regulation of calcium transients in diabetic vascular smooth muscle cells Am J Physiol Renal Physiol 285 2003 F1258 F1270
23. M. Saura, C. Zaragoza, W. Cao, C. Bao, M. Rodríguez-Puyol, and D. Rodríguez-Puyol et al. Smad2 mediates transforming growth factor-β induction of endothelial nitric oxide synthase expression Circ Res 91 2002 806 813
24. D.J. Grainger, P.R. Kemp, J.C. Metcalfe, A.C. Liu, R.M. Lawn, and N.R. Williams et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis Nat Med 1 1995 74 79
25. M. Schleicher, and W.C. Sessa Are the mechanisms for NO-dependent vascular remodeling different from vasorelaxation in vivo? Arterioscler Thromb Vasc Biol 28 2008 1207 1208
26. A.W. Chung, H.H. Yang, M.W. Radomski, and C. van Breemen Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9 Circ Res 102 2008 e73 e85
27. A.W. Chung, K. Au Yeung, G.G. Sandor, D.P. Judge, H.C. Dietz, and C. van Breemen Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome Circ Res 101 2007 512 522
28. A.W. Chung, P. Rauniyar, H. Luo, Y.N. Hsiang, C. van Breemen, and E.B. Okon Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production J Thorac Cardiovasc Surg 132 2006 925 932
29. A.W. Chung, P. Rauniyar, H. Luo, Y.N. Hsiang, C. van Breemen, and E.B. Okon Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9 J Vasc Surg 42 2005 747 756
30. A.W. Chung, Y.N. Hsiang, L.A. Matzke, B.M. McManus, C. van Breemen, and E.B. Okon Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature Circ Res 99 2006 140 148
31. A.W. Chung, K. Au Yeung, S.F. Cortes, G.G. Sandor, D.P. Judge, and H.C. Dietz et al. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome Br J Pharmacol 150 2007 1075 1083
32. A.W. Chung, H.H. Yang, and C. van Breemen Imbalanced synthesis of cyclooxygenase-derived thromboxane A(2) and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome Br J Pharmacol 152 2007 305 312
33. A.W. Chung, H.H. Yang, K. Au Yeung, and C. van Breemen Mechanical and pharmacological approaches to investigate the pathogenesis of Marfan syndrome in the abdominal aorta J Vas Res 45 2008 314 322